{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:08:08Z","timestamp":1791479288066,"version":"4.3.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T00:00:00Z","timestamp":1170720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T00:00:00Z","timestamp":1170720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>The etiology of osteoarthritis is multifactorial, with inflammatory, metabolic, and mechanical causes. Pain in osteoarthritis is initiated by mild intra-articular inflammation and degeneration of articular cartilage and subchondral bone. The principle of treatment with acetaminophen or non-steroidal anti-inflammatory drugs is to reduce pain and improve joint function. Recently, animal models for osteoarthritic pain behavior have been established. The most frequently used rat model for analyzing properties of drugs on the pathology of osteoarthritis is the injection of the metabolic inhibitor monosodium iodoacetate into the joint, which inhibits the activity of glyceraldehyde-3-phosphate dehydrogenase in chondrocytes. Here, we characterize the effect on pain behavior of lacosamide, a member of a family of functionalized amino acids that are analogues of endogenous amino acids and D-serine, in the monosodium iodoacetate rat model for osteoarthritis in comparison to diclofenac and morphine. Lacosamide (3, 10, and 30 mg\/kg) was able to reduce secondary mechanical allodynia and hyperalgesia similarly to morphine (3 mg\/kg). In contrast, diclofenac (30 mg\/kg) was only effective in reducing secondary mechanical hyperalgesia. During the first week, pain is induced mainly by inflammation in the iodoacetate model, but afterwards inflammation plays only a minor role in pain. Lacosamide was able to inhibit pain at days 3, 7 and 14 after induction of arthritis. This shows that lacosamide is able to reduce pain behavior induced by multiple mechanisms in animals.<\/jats:p>","DOI":"10.1186\/ar2121","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T19:53:24Z","timestamp":1170791604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain"],"prefix":"10.1186","volume":"9","author":[{"given":"Bettina","family":"Beyreuther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"Callizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"St\u00f6hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,6]]},"reference":[{"key":"1985_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/ar1450","volume":"6","author":"J Witter","year":"2004","unstructured":"Witter J, Dionne RA: What can chronic arthritis pain teach about developing new analgesic drugs?. Arthritis Res Ther. 2004, 6: 279-281. 10.1186\/ar1450.","journal-title":"Arthritis Res Ther"},{"key":"1985_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2005.01.013","volume":"35","author":"P Sarzi-Puttini","year":"2005","unstructured":"Sarzi-Puttini P, Cimmino MA, Scarpa R, Caporali R, Parazzini F, Zaninelli A, Atzeni F, Canesi B: Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum. 2005, 35: 1-10. 10.1016\/j.semarthrit.2005.01.013.","journal-title":"Semin Arthritis Rheum"},{"key":"1985_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/01.bor.0000172800.49120.97","volume":"17","author":"DT Felson","year":"2005","unstructured":"Felson DT: The sources of pain in knee osteoarthritis. Curr Opin Rheumatol. 2005, 17: 624-628. 10.1097\/01.bor.0000172800.49120.97.","journal-title":"Curr Opin Rheumatol"},{"key":"1985_CR4","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/01.hco.0000136130.95746.14","volume":"16","author":"B Hinz","year":"2004","unstructured":"Hinz B, Brune K: Pain and osteoarthritis: new drugs and mechanisms. Curr Opin Rheumatol. 2004, 16: 628-633. 10.1097\/01.hco.0000136130.95746.14.","journal-title":"Curr Opin Rheumatol"},{"key":"1985_CR5","first-page":"363","volume":"1","author":"AM Bendele","year":"2001","unstructured":"Bendele AM: Animal models of osteoarthritis. J Musculoskelet Neuronal Interact. 2001, 1: 363-376.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"1985_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/01926230390241800","volume":"31","author":"RE Guzman","year":"2003","unstructured":"Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K: Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol. 2003, 31: 619-624.","journal-title":"Toxicol Pathol"},{"key":"1985_CR7","first-page":"130","volume":"14","author":"DA Kalbhen","year":"1987","unstructured":"Kalbhen DA: Chemical model of osteoarthritis \u2013 a pharmacological evaluation. J Rheumatol. 1987, 14: 130-131.","journal-title":"J Rheumatol"},{"key":"1985_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1063-4584(03)00163-8","volume":"11","author":"SE Bove","year":"2003","unstructured":"Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, Kilgore KS: Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage. 2003, 11: 821-830. 10.1016\/S1063-4584(03)00163-8.","journal-title":"Osteoarthritis Cartilage"},{"key":"1985_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.neulet.2004.08.023","volume":"370","author":"R Combe","year":"2004","unstructured":"Combe R, Bramwell S, Field MJ: The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats?. Neurosci Lett. 2004, 370: 236-240. 10.1016\/j.neulet.2004.08.023.","journal-title":"Neurosci Lett"},{"key":"1985_CR10","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/art.1780400917","volume":"40","author":"C Guingamp","year":"1997","unstructured":"Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P: Mono-iodoacetate-induced experimental osteoarthritis: a dose\u2013response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum. 1997, 40: 1670-1679. 10.1002\/art.1780400917.","journal-title":"Arthritis Rheum"},{"key":"1985_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1292\/jvms.65.1195","volume":"65","author":"K Kobayashi","year":"2003","unstructured":"Kobayashi K, Imaizumi R, Sumichika H, Tanaka H, Goda M, Fukunari A, Komatsu H: Sodium iodoacetate-induced experimental osteoarthritis and associated pain model in rats. J Vet Med Sci. 2003, 65: 1195-1199. 10.1292\/jvms.65.1195.","journal-title":"J Vet Med Sci"},{"key":"1985_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pain.2004.08.004","volume":"112","author":"J Fernihough","year":"2004","unstructured":"Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, Kidd B, Bevan S, Winter J: Pain related behaviour in two models of osteoarthritis in the rat knee. Pain. 2004, 112: 83-93. 10.1016\/j.pain.2004.08.004.","journal-title":"Pain"},{"key":"1985_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejpain.2005.04.002","volume":"10","author":"T Stohr","year":"2006","unstructured":"Stohr T, Krause E, Selve N: Lacosamide displays potent antinociceptive effects in animal models for inflammatory pain. Eur J Pain. 2006, 10: 241-249. 10.1016\/j.ejpain.2005.04.002.","journal-title":"Eur J Pain"},{"key":"1985_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2006.04.009","volume":"539","author":"B Beyreuther","year":"2006","unstructured":"Beyreuther B, Callizot N, Stohr T: Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. Eur J Pharmacol. 2006, 539: 64-70. 10.1016\/j.ejphar.2006.04.009.","journal-title":"Eur J Pharmacol"},{"key":"1985_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neulet.2003.08.036","volume":"352","author":"G McCleane","year":"2003","unstructured":"McCleane G, Koch B, Rauschkolb C: Does SPM927 have an analgesic effect in human neuropathic pain? An open label study. Neurosci Lett. 2003, 352: 117-120. 10.1016\/j.neulet.2003.08.036.","journal-title":"Neurosci Lett"},{"key":"1985_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/1529-0131(199904)42:3<397::AID-ANR1>3.0.CO;2-X","volume":"42","author":"D Holderbaum","year":"1999","unstructured":"Holderbaum D, Haqqi TM, Moskowitz RW: Genetics and osteoarthritis: exposing the iceberg. Arthritis Rheum. 1999, 42: 397-405. 10.1002\/1529-0131(199904)42:3<397::AID-ANR1>3.0.CO;2-X.","journal-title":"Arthritis Rheum"},{"key":"1985_CR17","first-page":"5","volume":"2","author":"B Heppelmann","year":"1997","unstructured":"Heppelmann B: Anatomy and histology of joint innervation. J Peripher Nerv Syst. 1997, 2: 5-16.","journal-title":"J Peripher Nerv Syst"},{"key":"1985_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0306-4522(02)00165-3","volume":"113","author":"DB Mach","year":"2002","unstructured":"Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, Keyser CP, Clohisy DR, Adams DJ, O'Leary P, Mantyh PW: Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience. 2002, 113: 155-166. 10.1016\/S0306-4522(02)00165-3.","journal-title":"Neuroscience"},{"key":"1985_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1749-6632.2002.tb04234.x","volume":"966","author":"HG Schaible","year":"2002","unstructured":"Schaible HG, Ebersberger A, Von Banchet GS: Mechanisms of pain in arthritis. Ann NY Acad Sci. 2002, 966: 343-354.","journal-title":"Ann NY Acad Sci"},{"key":"1985_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/00003086-200007000-00024","volume":"376","author":"T Saito","year":"2000","unstructured":"Saito T, Koshino T: Distribution of neuropeptides in synovium of the knee with osteoarthritis. Clin Orthop Relat Res. 2000, 376: 172-182. 10.1097\/00003086-200007000-00024.","journal-title":"Clin Orthop Relat Res"},{"key":"1985_CR21","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/art.11094","volume":"48","author":"L Haywood","year":"2003","unstructured":"Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA: Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum. 2003, 48: 2173-2177. 10.1002\/art.11094.","journal-title":"Arthritis Rheum"},{"key":"1985_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.pain.2004.11.008","volume":"114","author":"JD Pomonis","year":"2005","unstructured":"Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, Walker K: Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain. 2005, 114: 339-346. 10.1016\/j.pain.2004.11.008.","journal-title":"Pain"},{"key":"1985_CR23","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/sj.bjp.0701320","volume":"121","author":"MJ Field","year":"1997","unstructured":"Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L: Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol. 1997, 121: 1513-1522. 10.1038\/sj.bjp.0701320.","journal-title":"Br J Pharmacol"},{"key":"1985_CR24","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/00000542-200211000-00033","volume":"97","author":"RW Hurley","year":"2002","unstructured":"Hurley RW, Chatterjea D, Rose Feng M, Taylor CP, Hammond DL: Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia. Anesthesiology. 2002, 97: 1263-1273. 10.1097\/00000542-200211000-00033.","journal-title":"Anesthesiology"},{"key":"1985_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1124\/jpet.103.050781","volume":"306","author":"Y Nagakura","year":"2003","unstructured":"Nagakura Y, Okada M, Kohara A, Kiso T, Toya T, Iwai A, Wanibuchi F, Yamaguchi T: Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J Pharmacol Exp Ther. 2003, 306: 490-497. 10.1124\/jpet.103.050781.","journal-title":"J Pharmacol Exp Ther"},{"key":"1985_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0304-3959(00)00404-8","volume":"90","author":"S Patel","year":"2001","unstructured":"Patel S, Naeem S, Kesingland A, Froestl W, Capogna M, Urban L, Fox A: The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain. 2001, 90: 217-226. 10.1016\/S0304-3959(00)00404-8.","journal-title":"Pain"},{"key":"1985_CR27","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.neuropharm.2006.02.002","volume":"50","author":"AC Errington","year":"2006","unstructured":"Errington AC, Coyne L, Stohr T, Selve N, Lees G: Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacology. 2006, 50: 1016-1029. 10.1016\/j.neuropharm.2006.02.002.","journal-title":"Neuropharmacology"},{"key":"1985_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neuropharm.2005.08.016","volume":"50","author":"G Lees","year":"2006","unstructured":"Lees G, Stohr T, Errington AC: Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro. Neuropharmacology. 2006, 50: 98-110. 10.1016\/j.neuropharm.2005.08.016.","journal-title":"Neuropharmacology"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2121\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:28:59Z","timestamp":1728383339000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,6]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,2]]}},"alternative-id":["1985"],"URL":"https:\/\/doi.org\/10.1186\/ar2121","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,6]]},"assertion":[{"value":"6 July 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R14"}}